Evolving options for the treatment of metastatic breast cancer: Progression-free survival as an endpoint

by Hurvitz, Sara A.
Published 2011

Neratinib Plus Capecitabine Provides a Glimmer of Hope for a Daunting Disease

by Hurvitz, Sara A.
Published in J Clin Oncol (2019)

The potential for trastuzumab emtansine in human epidermal growth factor receptor 2 positive metastatic breast cancer: latest evidence and ongoing studies

by Hurvitz, Sara A., Kakkar, Reva
Published 2012

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer

by Hurvitz, Sara A, Kakkar, Reva
Published 2012

Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer

by Peddi, Parvin F, Hurvitz, Sara A
Published 2013

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

by Peddi, Parvin F., Hurvitz, Sara A.
Published 2014

Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potential

by Peddi, Parvin F., Hurvitz, Sara A.
Published 2014

Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine

by Sadeghi, Saeed, Olevsky, Olga, Hurvitz, Sara A
Published 2014

Recent advances in the development of anti-HER2 antibodies and antibody-drug conjugates

by Wong, Deborah J.L., Hurvitz, Sara A.
Published in Ann Transl Med (2014)

Advances in the use of PARP inhibitor therapy for breast cancer

by McCann, Kelly E, Hurvitz, Sara A
Published in Drugs Context (2018)

Harnessing the immune system in the battle against breast cancer

by Nakasone, Elizabeth S, Hurvitz, Sara A, McCann, Kelly E
Published in Drugs Context (2018)

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer

by Hurvitz, Sara A., Lalla, Deepa, Crosby, Ross D., Mathias, Susan D.
Published 2013

Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping review

by Kolberg, Hans-Christian, Jackisch, Christian, Hurvitz, Sara A., Winstone, Julie, Barham, Helen, Hanes, Vladimir, Courmier, Delphine
Published in Breast (2021)

SERUM THYROTROPIN CONCENTRATIONS ARE NOT PREDICTIVE OF AGGRESSIVE BREAST CANCER BIOLOGY IN EUTHYROID INDIVIDUALS

by Villa, Natalie M., Li, Ning, Yeh, Michael W., Hurvitz, Sara A., Dawson, Nicole A., Leung, Angela M.
Published in Endocr Pract (2015)

Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patient...

by Perez, Edith A, Hurvitz, Sara A, Amler, Lukas C, Mundt, Kirsten E, Ng, Vivian, Guardino, Ellie, Gianni, Luca
Published in Breast Cancer Res (2014)

Clinical features of pseudocirrhosis in metastatic breast cancer

by Oliai, Caspian, Douek, Michael L., Rhoane, Caelainn, Bhutada, Abhishek, Ge, Phillip S., Runyon, Bruce A., Wang, Xiaoyan, Hurvitz, Sara A.
Published in Breast Cancer Res Treat (2019)

Clinical evaluation of BCL-2/X(L) levels pre- and post- HER2-targeted therapy

by Zoeller, Jason J., Press, Michael F., Selfors, Laura M., Dering, Judy, Slamon, Dennis J., Hurvitz, Sara A., Brugge, Joan S.
Published in PLoS One (2021)

Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens

by Hansen, Ryan N, Ramsey, Scott D, Lalla, Deepa, Masaquel, Anthony, Kamath, Tripthi, Brammer, Melissa, Hurvitz, Sara A, Sullivan, Sean D
Published 2014

Totality of Scientific Evidence in the Development of ABP 980, a Biosimilar to Trastuzumab

by Kolberg, Hans-Christian, Colleoni, Marco, Santi, Patricia, Demetriou, Georgia Savva, Segui-Palmer, Miguel Angel, Fujiwara, Yasuhiro, Hurvitz, Sara A., Hanes, Vladimir
Published in Target Oncol (2019)

Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer

by Bower, Julienne E., Asher, Arash, Garet, Deborah, Petersen, Laura, Ganz, Patricia A., Irwin, Michael, Cole, Steve W., Hurvitz, Sara A., Crespi, Catherine M.
Published in Cancer (2018)